Miyuki Tsumura

Miyuki Tsumura

Auto-generated profile, based on publicly available information

Miyuki Tsumura

Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KMKunihiko Moriya
Kunihiko Moriya
TNTomohiro Nakano
Tomohiro Nakano
YHYoshitaka Honda
Yoshitaka Honda
MTMiyuki Tsumura
Miyuki Tsumura
MOMasato Ogishi
Masato Ogishi
SKShigeo Kure
Shigeo Kure
Inborn errors of the NF-κB pathways underlie various clinical phenotypes in humans. Heterozygous germline loss-of-expression and loss-of-function mutations in RELA underlie RELA haploinsufficiency, which results in TNF-dependent chronic mucocutaneous ulceration and autoimmune hematological disorders. We here report six patients from five families with additional autoinflammatory and autoimmune manifestations. These patients are heterozygous for RELA mutations, all of which are in the 3′ segment of the gene and create a premature stop codon. Truncated and loss-of-function RelA proteins are expressed in the patients’ cells and exert a dominant-negative effect. Enhanced expression of TLR7 and MYD88 mRNA in plasmacytoid dendritic cells (pDCs) and non-pDC myeloid cells results in enhanced TLR7-driven secretion of type I/III interferons (IFNs) and interferon-stimulated gene expression in patient-derived leukocytes. Dominant-negative mutations in RELA thus underlie a novel form of type I interferonopathy with systemic autoinflammatory and autoimmune manifestations due to excessive IFN production, probably triggered by otherwise non-pathogenic TLR ligands.

4 January 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
PBPaul Bastard
Paul Bastard
AGAdrian Gervais
Adrian Gervais
MTMaki Taniguchi
Maki Taniguchi
LSLiisa Saare
Liisa Saare
KSKarita Särekannu
Karita Särekannu
JCJean-Laurent Casanova
Jean-Laurent Casanova
We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-α2 in 10 patients: IFN-α2 only in three, IFN-α2 plus IFN-ω in five, and IFN-α2, IFN-ω plus IFN-β in two; IFN-ω only in nine patients). Seven children (3.8%) had Abs neutralizing at least 10 ng/ml of one IFN, whereas the other 12 (6.6%) had Abs neutralizing only 100 pg/ml. The auto-Abs neutralized both unglycosylated and glycosylated IFNs. We also detected auto-Abs neutralizing 100 pg/ml IFN-α2 in 4 of 2,267 uninfected children (0.2%) and auto-Abs neutralizing IFN-ω in 45 children (2%). The odds ratios (ORs) for life-threatening COVID-19 pneumonia were, therefore, higher for auto-Abs neutralizing IFN-α2 only (OR [95% CI] = 67.6 [5.7–9,196.6]) than for auto-Abs neutralizing IFN-ω only (OR [95% CI] = 2.6 [1.2–5.3]). ORs were also higher for auto-Abs neutralizing high concentrations (OR [95% CI] = 12.9 [4.6–35.9]) than for those neutralizing low concentrations (OR [95% CI] = 5.5 [3.1–9.6]) of IFN-ω and/or IFN-α2.


8 February 2021 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
YIYusuke Imanaka
Yusuke Imanaka
MTMaki Taniguchi
Maki Taniguchi
TDTakehiko Doi
Takehiko Doi
MTMiyuki Tsumura
Miyuki Tsumura
RNRie Nagaoka
Rie Nagaoka
SOSatoshi Okada
Satoshi Okada

20 October 2020 in Journal of Clinical Immunology
Verified
Journal Article
Open access
PDF file
SNShiho Nishimura
Shiho Nishimura
YKYoshiyuki Kobayashi
Yoshiyuki Kobayashi
HOHidenori Ohnishi
Hidenori Ohnishi
KMKunihiko Moriya
Kunihiko Moriya
MTMiyuki Tsumura
Miyuki Tsumura
MKMasao Kobayashi
Masao Kobayashi
IRAK4 deficiency is an inborn error of immunity predisposing patients to invasive pyogenic infections. Currently, there is no established simple assay that enables precise characterization of IRAK4 mutant alleles in isolation. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune condition that is characterized by psychiatric symptoms, involuntary movement, seizures, autonomic dysfunction, and central hypoventilation. It typically occurs in adult females associated with tumors. Only a few infantile cases with anti-NMDAR encephalitis have been so far reported. We identified a 10-month-old boy with IRAK4 deficiency presenting with anti-NMDAR encephalitis and human herpes virus 6 (HHV6) reactivation. The diagnosis of IRAK4 deficiency was confirmed by the identification of compound heterozygous mutations c.29_30delAT (p.Y10Cfs*9) and c.35G>C (p.R12P) in the IRAK4 gene, low levels of IRAK4 protein expression in peripheral blood, and defective fibroblastic cell responses to TLR and IL-1 (TIR) agonist. We established a novel NF-κB reporter assay using IRAK4-null HEK293T, which enabled the precise evaluation of IRAK4 mutations. Using this system, we confirmed that both novel mutations identified in the patient are deleterious. Our study provides a new simple and reliable method to analyze IRAK4 mutant alleles. It also suggests the possible link between inborn errors of immunity and early onset anti-NMDAR encephalitis.